Nobuaki Fukushima, Yuma Kawamura, Shun Ukai, Ken Sagou, Miyo Goto, Kazutaka Ozeki, Akio Kohno (Department of Hematology and Oncology, Konan Kosei Hosipital, Konan, Japan)
Session information
Oral Session
Oral Session 2-11B AML: Clinical Study (2)
Sat. Oct 12, 2019 10:10 AM - 11:10 AM No.11 (Tokyo International Forum, 5F G502)
Chair: Yukiyasu Ozawa (Japanese Red Cross Nagoya First Hospital)
Tomohiko Tanigawa, Aki Sakurai, Yuriko Fujita, Masahiro Akimoto, Shinji Ogura, Ayana Uchimura, Chisako Ito, Yoshinobu Aisa, Tomonori Nakazato (Hematol, Yokohama Municipal Citizen's Hospital, Yokohama, Japan)
Tomohiko Kamimura1, Ken Takase2, Koji Kato3, Takatoshi Aoki1, Tetsuya Eto4, Ryosuke Ogawa5, Tomoaki Fujisaki6, Naoyuki Uchida7, Motoaki Shiratsuchi8, Kazuki Tanimoto9, Yuju Ohno10, Hiromi Iwasaki2, Koji Nagafuji11, Takanori Teshima12, Shuichi Taniguchi7, Toshihiro Miyamoto3, Koichi Akashi3, Mine Harada13 (1.Department of Hematology, Harasanshin Hospital, Fukuoka, Japan, 2.Department of Hematology, National Kyushu Medical Center, Fukuoka, Japan, 3.Department of Hematology, Kyushu University Hospital, Fukuoka Japan, 4.Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan, 5.Department of Hematology, JCHO Kyushu Hospital, Kita-Kyushu, Japan, 6.Department of Internal Medicine, Matsuyama Red Cross Hospital, Matsuyama, Japan, 7.Department of Hematology, Toranomon Hospital, Tokyo, Japan, 8.3rd Deaprtment of Internal Medicine, Kyushu University Hospital, Fukuoka, Japan, 9.Department of Hematology/Oncology, Fukuoka Red Cross Hospital, Fukuoka, Japan, 10.Department of Hematology, Kitakyushu City Hospital, Fukuoka, Japan, 11.Department of Hematology/Oncology, Kurume University Hospital, Kurume, Japan, 12.Department of Hematology, Hokkaido University Hospital, Sapporo, Japan, 13.Medical Center for Karatsu-Higashimatsuura Medical Association, Karatsu, Japan)
Marika Kuboyama1, Kenta Date1, Masahiro Sakaguchi1, Toshimitsu Ueki2, Kensuke Usuki3, Yutaka Kobayashi4, Kenji Tajika5, Seiji Gomi5, Saiko Kurosawa6, Taichiro Tokura1, Kazuki Inai1, Daishi Onai1, Atsushi Marumo1, Ikuko Omori1, Satoshi Yamanaka1, Yusuke Fujiwara1, Shunsuke Yui1, Satoshi Wakita1, Muneo Okamoto1, Miho Miyata1, Kunihito Arai1, Tomoaki Kitano1, Kazuki Terada1, Takahiro Fukuda6, Hiroki Yamaguchi1, Koichi Inokuchi1 (1.Department of Hematology, Nippon Medical School, Tokyo, Japan, 2.Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan, 3.Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan, 4.Hematology Division, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan, 5.Department of Hematology, Yokohama Minami Kyousai Hospital, Kanagawa, Japan, 6.Department of HSCT, National Cancer Center Hospital, Tokyo, Japan)
Yoshimasa Kamoda, Akira Hangaishi, Yusuke Uchibori, Hiromitsu Iizuka, Michiko Kida, Kensuke Usuki (Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan)
Daiki Hirano, Hiroatsu Iida, Yoshino Kawaguchi, Sonoko Shimoji, Takashi Tokunaga, Hirokazu Nagai (Dept. Hematology., National Hospital Organization Nagoya Medical Center., Nagoya, Japan)